Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Ligand Binding Sites02:40

Ligand Binding Sites

14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Ligand Binding Sites02:40

Ligand Binding Sites

8.6K
8.6K
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

14.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.9K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

4.0K
4.0K
Conserved Binding Sites01:49

Conserved Binding Sites

5.0K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
5.0K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

An integrated experimental and computational pipeline for crystallographic fragment screening of membrane protein in the lipid cubic phase.

Communications chemistry·2026
Same author

Quantifying Spatially Resolved Hydration Thermodynamics Using Grid Inhomogeneous Solvation Theory [Article v1.0].

Living journal of computational molecular science·2026
Same author

Structure-Based Experimental Datasets for Benchmarking Protein Simulation Force Fields [Article v1.0].

Living journal of computational molecular science·2026
Same author

Relative BAT: An Automated Tool for Relative Binding Free Energy Calculations by the Separated Topologies Approach.

Journal of chemical information and modeling·2025
Same author

Expediting hit-to-lead progression in drug discovery through reaction prediction and multi-dimensional optimization.

Nature communications·2025
Same author

The Parkinson's Disease Drug Tolcapone and Analogues are Potent Glycomimetic Lectin Inhibitors of Pseudomonas aeruginosa LecA.

Angewandte Chemie (International ed. in English)·2025

相关实验视频

Updated: Jan 16, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

1.7K

CASP 16 实验性蛋白质 - 连接体数据集

Andreas Tosstorff1, Markus G Rudolph1, Jörg Benz1

  • 1Roche Pharmaceutical Research and Early Development (pRED), Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., Basel, Switzerland.

Proteins
|October 3, 2025
PubMed
概括

这项研究引入了CASP16.16药物发现中的新型蛋白质-配体数据集. 这些基准数据集评估药物相关目标的计算方法.

关键词:
在SARS-CoV-2主要蛋白酶中.自动出租车 (Autotaxin) 是一种自动出租车.一个基准的基准指标.卡特赫普辛G G G 卡特赫普辛G 卡特赫普辛G G 卡特赫普辛G基酶 基酶 是一种结晶化 结晶化的过程.发现药物的发现.连接器 连接器 连接器蛋白质蛋白质是一种蛋白质蛋白质.

更多相关视频

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports
05:18

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

2.6K
Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry
13:26

Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry

Published on: September 13, 2014

62.7K

相关实验视频

Last Updated: Jan 16, 2026

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
05:56

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches

Published on: October 13, 2022

1.7K
Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports
05:18

Quaternary Structure Modeling Through Chemical Cross-Linking Mass Spectrometry: Extending TX-MS Jupyter Reports

Published on: October 20, 2021

2.6K
Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry
13:26

Determination of Protein-ligand Interactions Using Differential Scanning Fluorimetry

Published on: September 13, 2014

62.7K

科学领域:

  • 结构生物学 结构生物学
  • 药物发现 药物发现 药物发现
  • 计算化学计算化学

背景情况:

  • CASP (蛋白质结构预测的批判性评估) 实验传统上专注于蛋白质结构预测.
  • 药物发现项目的整合到CASP16中标志着对现实世界药物开发挑战的重大扩展.

研究的目的:

  • 为CASP16提供实验性蛋白质 - 配体数据集,特别是用于药物发现目标.
  • 为制药应用建立评估蛋白质 - 连接体姿势和亲和力预测计算方法的基准.

主要方法:

  • 对四种药物标蛋白质的蛋白质-连接体复合物的组装和表征:人体化学酶,人体甲素G,人体自毒素和SARS-CoV-2主要蛋白酶.
  • 收集了200多个共同晶体结构 (分辨率<2.7 Å) 和约160个化合物 (纳米到高微分子范围) 的结合亲和度测量.
  • 实验方法的详细描述,包括蛋白质生产,结晶和结合试验的开发.

主要成果:

  • 创建基准数据集,其中包括具有药学意义的蛋白质-联结体复合体.
  • 包括具有具有挑战性特征的系统,例如特定的蛋白质表面,连接体特性和活性位点构造.
  • 从实际的药物发现项目中生成数据,提供现实的测试平台.

结论:

  • 提出的数据集对于通过提供现实的基准来推进计算药物发现至关重要.
  • 这些数据集将有助于评估计算方法对药物研究相关目标的性能.
  • 该研究强调了药物发现项目的成功整合到CASP框架.